Does Rallies show CNTA 10-K and 10-Q filings?

Rallies organizes CNTA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is CNTA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CNTA. It does not provide personalized investment advice.

CNTA (Centessa Pharmaceuticals plc American Depositary Shares) Stock Analysis - SEC Filings

Centessa Pharmaceuticals plc American Depositary Shares (CNTA) is a publicly traded Healthcare sector company. As of May 20, 2026, CNTA trades at $39.55 with a market cap of $6.13B and a P/E ratio of -27.22. CNTA moved +0.18% today. Year to date, CNTA is +72.68%; over the trailing twelve months it is +201.14%. Its 52-week range spans $9.60 to $40.26. Analyst consensus is neutral with an average price target of $42.40. Rallies surfaces CNTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CNTA SEC filings?

Rallies organizes CNTA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CNTA Key Metrics

Key financial metrics for CNTA
Metric	Value
Price	$39.55
Market Cap	$6.13B
P/E Ratio	-27.22
EPS	$-1.46
Dividend Yield	0.00%
52-Week High	$40.26
52-Week Low	$9.60
Volume	814.63K
Avg Volume	0
Revenue (TTM)	$15.00M
Net Income	$-197.53M
Gross Margin	0.00%

Latest CNTA News

Law Firm Challenges Centessa $38 Cash Plus Up to $9 CVR Sale to Lilly — May 12, 2026
Eli Lilly to Acquire Centessa for $7.8B Including $38 Cash, $9 CVRs — Apr 2, 2026
Centessa Pharmaceuticals Shares Soar 44.4% to $39.90 on $6.3B Eli Lilly Deal — Mar 31, 2026
Eli Lilly to Acquire Centessa for $38 per Share, Up to $7.8B — Mar 31, 2026

Recent CNTA Insider Trades

Anderson Karen M. sold 41.08K (~$1.24M) on Mar 26, 2026.
Weinhoff Gregory M sold 24.00K (~$719.94K) on Mar 26, 2026.
Anderson Karen M. sold 10.04K (~$282.21K) on Mar 17, 2026.

CNTA Analyst Consensus

10 analysts cover CNTA: 0 strong buy, 1 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $42.40.

Common questions about CNTA

Where can I find CNTA SEC filings?: Rallies organizes CNTA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CNTA 10-K and 10-Q filings?: Rallies organizes CNTA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CNTA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CNTA. It does not provide personalized investment advice.